Management and outcomes of obstructive sleep apnea in children with Robin sequence, a cross-sectional study by Lieshout, M.J.S. (Manouk) van et al.
ORIGINAL ARTICLE
Management and outcomes of obstructive sleep apnea in children
with Robin sequence, a cross-sectional study
Manouk J.S. van Lieshout1,2 & Koen F.M. Joosten3,2 & Maarten J. Koudstaal1,2 &
Marc P. van der Schroeff4,2 & Karolijn Dulfer5,2 & Irene M.J. Mathijssen6,2 &
Eppo B. Wolvius1,2
Received: 12 November 2015 /Accepted: 20 October 2016
# The Author(s) 2016. This article is published with open access at Springerlink.com
Abstract
Objective The objective of this cross-sectional study is to as-
sess the prevalence, course, and management of obstructive
sleep apnea (OSA) in children with Robin sequence (RS) aged
1–18 years.
Materials and methods A cross-sectional study was conduct-
ed in 63 children aged 1 to18 years with RS. Patient data were
collected on baseline characteristics and management. OSA
was evaluated by polysomnography.
Results Sixty-three children with RS were included (median
age 8.0 years) and divided into two groups based on the initial
treatment: prone positioning or respiratory support.
Respiratory support was more often indicated in children with
a non-isolated RS (p < 0.05). At cross section, in the prone
positioning group (n = 32), one child was diagnosed with
OSA. In the respiratory support group (n = 31), 13 children
(42 %) had respiratory problems of whom 10 needed respira-
tory support.
Conclusions Between the age of 1 and 18 years, almost one
out of four children with RS still has respiratory problems.
Children with RS, who can be treated with prone positioning
only as an infant, are not likely to develop obstructive airway
problems at a later age. In contrast, children who need respi-
ratory support early after birth are at risk of continuing or re-
developing OSA after the age of 1 year.
Clinical relevance This study shows that those who need re-
spiratory support at an early age need careful monitoring until
adulthood.
Keywords Robin sequence . Airway obstruction .
Obstructive sleep apnea . Treatment
Introduction
Robin sequence (RS) is a congenital facial condition occurring
in 1 in 5600 to 1 in 30,000 newborns [1–5]. The condition is
classically characterized by an underdeveloped mandible
(mandibular hypoplasia), backward displacement of the
tongue (glossoptosis), and airway obstruction. In 80–90 %
of the RS cases, a cleft palate is present [4, 6, 7].
Children with RS are at risk of developing obstructive sleep
apnea (OSA) [8]. OSA is characterized by prolonged partial
upper airway obstruction and/or intermittent complete airway
obstruction, disrupting the child’s sleeping pattern [9].
Leaving OSA untreated may result in serious morbid conse-
quences on the cardiovascular system, the metabolic system,
and neurocognitive and behavioral functioning [9]. To estab-
lish the presence of OSA, polysomnography (PSG) is current-
ly considered the gold standard [10].
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The prevalence of respiratory problems in infants with RS
is considerably high with reported OSA prevalence rates be-
tween 46 and 100 % depending on the criteria used [11, 12, 8,
13, 14]. However, to our knowledge, no follow-up studies on
OSA have been conducted in children with RS beyond the
infant period.
The aim of this cross-sectional study was to examine the
prevalence, course, and management of OSA in children over
the age of 1 year with RS.
Material and methods
A cross-sectional study was carried out among children with
RS aged above 1 year combined with retrospective data col-
lection from the patients’ chart. Inclusion was based on his-
torical data of the Dutch Craniofacial Center, Erasmus
Medical Centre-Sophia’s Children Hospital. Children were
considered suitable for inclusion if they had been diagnosed
with RS, in this study defined as the presence of mandibular
hypoplasia and airway obstruction, and were aged between 1
and 18 years [15, 16]. The ethical committee of the Erasmus
Medical Centre (MEC-2012-048) approved the study. For all
participating children, parents and/or children (if above
12 years of age) provided written informed consent. As pri-
mary treatment providers, no approval of the ethical commit-
tee was necessary for the data collection of baseline character-
istics of the non-participants. Inclusion and study visits took
place between November 2012 and July 2015.
During the study visit, participants underwent PSG at home
or in the hospital. Furthermore, a retrospective chart review
was performed on the initial treatment of airway obstruction
from birth on until cross section. Based on these retrospective
data, children were divided into two groups: those who
initially had been treated with prone positioning and those
who initially had been treated with respiratory support.
Interventions of airway obstruction, which were performed
in other centers, were also taken into account in this review.
PSG results and treatment history were analyzed for these two
groups.
Polysomnography
In this study, ambulant sleep studies (level III, with data re-
corded by the Embletta portable diagnostic system) and clin-
ical sleep studies in the hospital (level I, i.e., attended PSG
including medical and technical support) were done. During
the sleep studies, a variety of cardiorespiratory variables were
assessed, including nasal airflow, chest and abdominal wall
motion, and arterial oxygen saturation. Data were analyzed
using Somnologica for Embletta software 3.3 ENU
(Medcare Flags, Reykjavik, Iceland) for ambulant studies
and Shell+ BrainRT Software Suite Version 2.0 (O.S.G.,
Rumst, Belgium) for clinical studies.
For analysis, we aimed for a total sleep time (TST) of at
least 360 min, free of artifact. Summary statistics and events
were scored according to the updated rules for scoring respi-
ratory events by the American Academy of Sleep Medicine
(AASM) [17]. An obstructive event was defined as a reduc-
tion in nasal airflow of ≥90% (apnea) or 30–90% (hypopnea)
for the duration of at least two breaths, in the presence of
thoracic and abdominal breathing movement. A hypopnea
was only included if it was associated with a subsequent
SpO2 desaturation of at least 3 % from baseline or with an
arousal. Central apnea/hypopnea meets the same criteria as its
obstructive counterpart, only without the presence of thoracic
and abdominal breathing movement. A mixed apnea is a com-
bination of a central apnea and an obstructive apnea. The
obstructive apnea–hypopnea index (oAHI) was calculated
by adding the number of obstructive apneas, mixed apneas,
and obstructive hypopneas with SpO2 desaturation, divided
by the TST; OSA was defined as an oAHI ≥1 per hour. An
oAHI ≥1 and <5 was defined as mild OSA, between ≥5 and
<25 as moderate OSA, and ≥25 as severe OSA [18].
Statistical analysis
To assess whether the participant group was not significantly
different from the non-participant group, baseline characteris-
tics were compared using Pearson’s chi-squared tests and in-
dependent Student t tests. In order to determine the mean age
at time of cross section in the group of non-participants, we
used the date halfway our study inclusion period as date of
cross section. A p value of <0.05 was considered to be statis-
tically significant. Analyses were performed with SPSS 20.0
for Windows (SPSS, Inc. Chicago, IL).
Results
Baseline characteristics
In total, 111 children with RS were eligible for inclusion of
whom 63 (57 %) RS patients and their parents gave informed
consent (Fig. 1). For 48 children, consent was not obtained
due to various reasons. In order to assess whether the study
sample was representative for the RS population in our hos-
pital, in Table 1, baseline characteristics of the study partici-
pants are compared with the non-participants. No significant
differences were found for mean age at cross section, sex,
presence of a syndrome or additional anomalies, presence of
a cleft palate, and initial treatment of airway obstruction.
Five children were deceased but were nonetheless included
in the calculations of the non-participation group. In two of
these cases, the cause of death was respiratory-related: one
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Table 1 Baseline characteristics of the study participants (n = 63) vs. non-participants (n = 48)
Participants (63) Non-participants (n = 48) p value
Median age in years at cross section (IQR) 8.0 (4.0–12.0) 9.0 (6.0–13.0) p = 0.57
Sex Female
Male
31 (49.2 %)
32 (50.8 %)
21 (43.8 %)
27 (56.3 %)
p = 0.57
Presence of a syndrome or additional anomalies Yes, additional anomalies
Yes, syndrome
No
19 (30.2 %)
7 (11.1 %)
37 (58,7 %)
14 (29.2 %)
13 (27.1 %)
21 (43.8 %)
p = 0.08
Presence of a cleft palate Yes
No
58 (92.1 %)
5 (7.9 %)
40 (83.3)
8 (16.7 %)
p = 0.16
Treatment of airway obstruction Prone positioning only
Non-surgical treatment
Surgical treatment
32 (50.8 %)
19 (30.2 %)
12 (19.0 %)
29 (60.4 %)
8 (16.7 %)
11 (22.9 %)
p = 0.19
IQR interquartile range
Fig. 1 Treatment overview of children with RS. I isolated, AA associated anomalies, S proven syndrome
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child with various comorbidities died at the age of 1 year due
to severe respiratory insufficiency following aspiration and
another child died within hours after birth due to severe
obstruction of the upper airway and no option for a
tracheostomy.
Thirty-one females and 32 males participated in the study.
Of these 63 children, 37 children had an isolated RS, while 26
children had additional anomalies (n = 19) or a syndrome
(n = 7); 2 children were diagnosed with Stickler syndrome,
1 child with Nager syndrome, 1 child with Shprintzen–
Goldberg syndrome, 1 child with acampomelic dysplasia, 1
child with a FOXC2 mutation, and 1 child with a MFDM
mutation. A variety of conditions were reported in the group
with associated anomalies such as psychomotor retardation,
hip dysplasia, or facial anomalies, but not with a proven syn-
drome. Five children had RS without a cleft palate.
The mean pregnancy duration was 38.5 weeks. Eight chil-
dren were born pre-term (<37 weeks). The mean birth weight
was 3137 g. Three families reported occurrence of mandibular
hypoplasia in the family.
Feeding difficulties were reported in 60 out of 63 (95.2 %)
children. Twenty-six children out of 63 (41.3 %) needed a
temporary feeding tube and seven children (11.1 %) a percu-
taneous endoscopic gastrostomy tube.
Prior to cross section: initial management of obstructive
sleep apnea
Figure 2 shows an overview of initial management (including
the findings at cross section). Initially, 32 children (48.5%)were
treated with prone positioning and 31 children were in need of
respiratory support, which consisted of non-surgical respiratory
support such as a nasopharyngeal tube, continuous positive air-
way pressure (CPAP), and oxygen therapy, or surgical measures
such as tracheostomy and mandibular distraction osteogenesis
with or without tracheostomy at the time of distraction. Children
with additional anomalies or a syndrome (n = 26) were in need
of respiratory support significantly more often compared to
those with an isolated RS (65.4 vs. 37.8 %, p < 0.05).
At cross section
The median age in years at cross section was 8.0 years (IQR
4.0–12.0). Thirty-one out of 63 (49.2 %) children were fe-
male. Thirty-seven children (58.7 %) had an isolated RS. A
cleft palate was present in 58 (92.1 %) children.
At cross section: assessment of obstructive sleep apnea
by polysomnography
From the 63 children in this study, in 19 no PSG result was
available, in 3 the parents refused, in 10 PSG failed due to logistic
reasons, and in 6 PSG was not indicative of OSA because of a
tracheostomy (n = 5) or CPAP (n = 1). These last six cases were
classified as having OSAwithout formal assessment. At the end,
44 PSG studies (n = 37 ambulatory and n = 7 clinical) were
available for analysis: 23 PSG studies in the group initially man-
aged with prone positioning (n = 32) and 21 PSG studies in the
group initially managed with respiratory support (n = 31).
OSAwas detected in six children who did not receive OSA
treatment at the time of cross section. Besides these six chil-
dren, OSA was confirmed in two other children who already
received respiratory support for OSA but a PSG was done
without this support as part of routine clinical evaluation.
Table 2 further elaborates on these cases.
At cross section: airway management
Out of the total group of 63 children, 14 (22%) received either
OSA treatment and/or showed OSA during PSG at cross
section.
In the cohort of the children (n = 32, mean age at cross
section 7.1 ± 4.5 years) who were initially treated with prone
positioning, in one child mild OSAwas found with PSG, but
further treatment was not necessary. Thirty-one out of 32
(96.9 %) children were free of OSA treatment at the time of
cross section.
In the cohort of children (n = 31, mean age at cross section
9.4 ± 5.8 years) who were initially treated by respiratory sup-
port, 13 children (42 %) had respiratory problems; 3 children
were still in need of non-surgical respiratory support (CPAP or
oxygen therapy) (age range at cross section 9.3–16.0 years),
and 5 children were dependent on a tracheostomy (age range
at cross section 1.8–7.7 years). In five children, OSA was
found (age range 1.5–16.4 years), and in two of these children
a re-start of respiratory support (CPAP) was indicated shortly
after PSG (Table 2). Eighteen out of 31 (58.1 %) children were
free of OSA or respiratory support at the time of cross section.
Discussion
To our knowledge, this is the first long-term follow-up study
investigating obstructive airway problems in children with RS
between 1 and 18 years of age. At cross section, 22 % of the
children with RS still had respiratory problems. Those who had a
history of only prone positioning were not likely to develop a
significant airway obstruction at a later age. However, children
who needed respiratory support early after birth were 13 times
more likely to be diagnosed with OSA at a later age or to remain
dependent on or re-develop a need for respiratory support.
In this study, children were divided into two groups on the
basis of their initial airway management. About half of the
children initially needed respiratory support for which differ-
ent respiratory support modalities were used. In eight children,
mandibular distraction osteogenesis had been performed. At
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Fig. 2 Treatment overview of study participants (n = 63) including the
(mean) follow-up duration and age at cross section. MDO mandibular
distraction osteogenesis, T tracheostomy, yrs age in years, mo age in
months. Presence of OSAwas based on PSG results (n = 44) (asterisk).
If no PSG was available, presence of OSA was based on the need for
treatment
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cross section, in six of these children mandibular distraction
osteogenesis was successful, although in two cases mild OSA
was diagnosed with PSG but no further treatment was neces-
sary. Two children still needed a tracheostomy at the time of
the study; however, follow-up after the mandibular distraction
osteogenesis was short. Also, two children who had received
non-surgical respiratory support shortly after birth were still
dependent on a tracheostomy.
Interestingly, four children became again in need of non-
surgical respiratory support at an older age, in two of them as a
result of this study. In a recent retrospective study of Lee et al.,
it was shown that their RS infant population, who were
followed to 1 year of age, did not show significant decreases
in AHI, oAHI, and central apnea index [19]. Unfortunately,
other studies with follow-up on OSA in RS patients are so far
lacking. On the basis of this study, one might conclude that the
group of children who initially needed respiratory support
might benefit from more careful monitoring until adulthood.
Remarkably, of those who were still in need of respiratory
support, six children had been diagnosedwith associated anom-
alies or a syndrome and only two with an isolated RS. In daily
practice (data not shown), many children with an associated
anomaly or a syndrome have an even smaller mandible than
those with an isolated RS. It is speculated that in children with
RS, with an intrinsic tissue deficiency as primary cause, there is
impaired growth of the mandible [20]. This may also explain
why this group of children needed respiratory support more of-
ten. Incontrast, in thecaseof isolatedRS, theremightbecatch-up
growth from an initial deformation [21]. However, there is an
ongoing discussion about the concept of accelerated growth of
the mandible. Previous studies showed a Bpartial mandibular
catch-up growth^ and an increase (3.5 times its original size) in
airway dimension in the first 2 years of life. Additionally, an
increase in upper airway dimensions in longitudinal
cephalograms of children with RS from childhood to adulthood
was noticed [22, 23]. Remarkably, the depth of the oropharyn-
gealairwaywasanexception to this. Incontrast, other studiesdid
not observe this acceleration of mandibular growth [24–26].
Since the upper airway is a three-dimensional and complex dy-
namic altering space, one may question whether the method of
analyzing two-dimensional radiographs (cephalogram) to deter-
mine alterations of airway space is the most appropriate one.
Ultimately, flexible fiberoptic laryngoscopy (FFL) of the
upper airway should determine the extent of the upper airway
obstruction, but validated scoring systems that objectify the
obstruction of the airway are lacking. A recent attempt to score
glossoptosis in RS patients using awake FFL was not success-
ful, due to disappointing inter- and intra-agreement in the
analysis of awake FFL videos of RS patients compared to
non-RS patients [27]. Another complicating factor is that the
degree of micrognathia does not seem to correlate well with
the degree of airway compromise and the higher Cormack–
Lehane grades diagnosed with laryngoscopy [28].
Limitations
Only about half the RS population participated, resulting in a
small sample size. Of some non-participants, there were no
data available on the further course of the obstructive prob-
lems. Nonetheless, a flowchart was created based on the latest
available data in the patient charts. In Table 1, it is shown that
Table 2 Overview of cases in whom OSAwas found during PSG (n = 44)
Case number, isolated or non-isolated,
age at cross section
History PSG at cross section
oAHI ODI
Case 1, isolated, 6.0 years Treated by prone positioning in the neonatal period and no complaints
afterwards. After PSG, the child was treated with nasal corticosteroids
because of mild–moderate OSA.
3.7 2.8
Case 2, associated anomalies, 1.5 years PSG for follow-up purposes and a wait-and-see policy was set. This child
was already known to have OSA and hypoventilation.
6.7 9.5
Case 3, syndromal, 6.8 years A nasopharyngeal tube shortly after birth for 5 months. After PSG, CPAP
was re-started because of moderate OSA.
17.0 20.9
Case 4, isolated, 16.4 years A few days of oxygen therapy at birth and afterwards treated with CPAP for
3 months. At the age of 16, severe complaints of OSA and re-start of CPAP
shortly after PSG
50.0 26.7
Case 5, associated anomalies, 16.0 years CPAP for 6.5 years until the age of 9 years, when mandibular distraction
osteogenesis was performed. Based upon the PSG results, a wait-and-see
policy was set.
3.2 0.7
Case 6, associated anomalies, 6.0 years Mandibular distraction osteogenesis and decannulation at the age of 3 months
and oxygen supplementation until the age of 6 years. Based upon the PSG
results, a wait-and-see policy was set.
7.3 8.9
Case 7, isolated, 9.3 years Six months of CPAP treatment at the age of 1 year and re-start of CPAP at
the age of 8 years. At home PSG without CPAP
3.0 0.2
Case 8, syndromal, 16.0 years Oxygen therapy since birth, at home PSG without oxygen 7.0 3.7
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our sample appears to be representative of the total RS popu-
lation in our clinic.
A PSG or appropriate PSG results were not available in all
participants. If there was no PSG result available at cross
section, the presence of OSA was determined by the child’s
current need for respiratory support. Because of this, results
from this study should be interpreted with caution.
Furthermore, our inclusion was based on historical data,
which is another limitation of this study. Especially, in the group
who was initially treated by prone positioning, one may argue
whether thesechildrenareBtrue^Robinsequencepatients.What
was the indication to start prone positioning?Whatwas the level
of airway obstruction? However, just the mere fact that these
childrenwere given a prone positioning advice despite knowing
the risks such as sudden infant death syndrome suggests that the
clinical issues must have been substantial.
Conclusion
This is the largest cross-sectional study on OSA in children
with RS to date. Half of the RS population had been treated
with prone positioning, while the other half needed respiratory
support. Children with RS, who were treated by prone posi-
tioning as an infant, appear to have a very low risk on obstruc-
tive pathology at a later age indicating some natural improve-
ment. Children who needed respiratory support continued or
re-developed dependence on respiratory support at a later age.
Considering the potential long-term effects of untreated OSA,
children with RS in which the airway obstruction cannot be
managed with prone positioning only require close follow-up
beyond the infant period preferably using PSG.
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